Document is current
Any future updates will be listed below
-
Authors
Elemento, Olivier https://orcid.org/0000-0002-8061-9617
Leslie, Christina https://orcid.org/0000-0002-4571-5910
Lundin, Johan
Tourassi, Georgia
- License Information
-
More Information
Article History
Accepted: 10 August 2021
First Online: 17 September 2021
Competing interests
: O.E. is supported by Janssen, Johnson & Johnson, AstraZeneca, Volastra and Eli Lilly research grants. He is a scientific advisor to and equity holder in Freenome, Owkin, Volastra Therapeutics and OneThree Biotech and is a paid scientific advisor to Champions Oncology. J.L. is a co-founder, shareholder and member of the Board of Directors of and receives consultation fees from Aiforia Technologies Oy. J.L. is also a founding member and an unpaid member of the Board of Advisors of the European Society of Digital and Integrative Pathology. C.L. and G.T. declare no competing interests.
